Walk into the emergency room at Israel’s largest hospital and the first clinician to take your history may be an AI avatar — with a physician signing off on every recommendation. Israel’s Sheba Medical Center is building what could become the first fully AI-based hospital by 2030. Dr. Eyal Zimlichman, Sheba’s Chief Transformation Officer, Chief…
By STEPHEN FARBER Part one argued that patient access was never the finish line; it was the foundation. This is about what we build now that we are standing on it. Every good game show has a second round, and the second round is always harder. The first round was about getting health information out…
AdvaMed CEO Scott Whitaker outlined four policy priorities at the MedTech Conference: tariffs, FDA user fees, payment and coverage, and cybersecurity. The post AdvaMed’s 4 Policy Priorities, According to Its CEO appeared first on MedCity News.
The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and a potential dosing advantage over a Takeda Pharmaceutical product recently approved in this indication. The post Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare…
Phantom GI, a Tel Aviv-based medical startup, is developing the PercStoma device, a minimally invasive alternative to traditional ostomy surgery. The device would target patients with bowel obstructions who might otherwise be considered ineligible for surgery. The post With $5M, Phantom GI Plans to Develop Minimally Invasive Alternative Ostomy Surgery Device appeared first on MedCity…
What percentage of people are covered by Medicaid in your state? Our State Medicaid fact sheets provide a snapshot with key data for Medicaid in every state related to current coverage, access, and financing, as well as a politics section for each state.
Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage. The post Diagnosis Is Beside the Point appeared first on MedCity News.
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Not-So-Great Healthcare Why doesn’t world-class medicine produce world-class health? Hayat Norimine’s reporting gets at something that has bothered me for a long time about American healthcare (Priced Out: “As Health Insurance…
Experimental peptides have become darlings among influencers, chiropractors, and doctors focused on longevity, antiaging, or “body optimization,” even though the FDA hasn’t approved them for safety or effectiveness. Health secretary Robert F. Kennedy Jr. and other leaders of the Make America Healthy Again movement have pushed to make unproven peptides more accessible — and they’ve…
Heading into the midterm elections, high healthcare costs rank among voters’ biggest concerns. But lately, there’s a twist giving the issue new momentum on campaign agendas: a focus on fraud in government health programs. The administration of President Donald Trump has used claims of widespread wrongdoing to justify investigations, suspensions of billions of dollars in…